ValiRx (LON:VAL) Issues Earnings Results

ValiRx (LON:VALGet Free Report) released its quarterly earnings results on Friday. The company reported GBX (1.45) (($0.02)) earnings per share for the quarter, Digital Look Earnings reports. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%.

ValiRx Stock Performance

Shares of LON VAL opened at GBX 0.49 ($0.01) on Friday. The stock has a market cap of £1.84 million, a price-to-earnings ratio of -0.33 and a beta of 0.59. The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.44. ValiRx has a 1-year low of GBX 0.38 ($0.01) and a 1-year high of GBX 3.50 ($0.05). The stock’s 50-day moving average is GBX 0.52 and its 200 day moving average is GBX 0.72.

ValiRx Company Profile

(Get Free Report)

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Read More

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.